Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neurology

Treatment Options and Standards of Care

At a Glance

Treatment for epilepsy with eyelid myoclonia usually starts with a medicine that treats several seizure types, often valproate. Levetiracetam or lamotrigine may be alternatives, and persistent seizures may lead to supervised dietary therapy or vagus nerve stimulation.

Important Warning: Never start, stop, or change your child’s antiseizure medication without direct guidance from their prescribing neurologist, as sudden changes can trigger severe seizures.

Deciding on a treatment path for epilepsy with eyelid myoclonia (EEM) requires balancing the goal of stopping the eyelid fluttering and absence seizures with the potential side effects of medications [1]. Because EEM is a generalized epilepsy, the medications chosen must be effective for generalized networks [2].

First-Line Treatment Options

There is no single “cure” for EEM, but international experts have reached a strong consensus on the most effective starting points [1][2]:

  • Valproate (Valproic Acid): This is widely considered the most effective medication for EEM [1][3]. It is a “broad-spectrum” drug, meaning it works well against all the seizure types seen in this syndrome, including eyelid fluttering, absences, and generalized convulsions [4].
  • Alternatives for Patients with Pregnancy Potential: Because valproate carries significant risks for fetal development (known as teratogenicity) and may affect reproductive health—such as a link to polycystic ovary syndrome in some patients—it is often avoided in anyone with future childbearing potential [5][6]. For these patients, doctors typically prefer:
    • Levetiracetam: A well-tolerated alternative with a lower risk profile for future pregnancies [1][7]. A key side effect to monitor is irritability or behavioral changes in some children.
    • Lamotrigine: Another common choice, though it requires a very slow dose increase to monitor for a potentially serious rash. Additionally, lamotrigine is itself a sodium-channel agent, and it can occasionally worsen certain types of “jerks” (myoclonus) in some children [1][8].

Medications to Avoid

In EEM, using the wrong medication can actually make the seizures worse. A group of narrow-spectrum drugs called sodium-channel blockers should generally be avoided because they are known to aggravate generalized seizures [1]. Common examples include:

  • Carbamazepine
  • Oxcarbazepine [9]
  • Phenytoin

Additionally, some isolated case reports have noted that cannabidiol (CBD) may worsen eyelid fluttering in children with EEM, so it should be used with caution and close supervision [10].

Second-Line and “Add-on” Therapies

If the first medication does not fully control the seizures, your doctor may suggest adding a second drug or switching to another option. There is moderate expert consensus that the following can be helpful [1]:

  • Ethosuximide: Primarily used if absence seizures (staring spells) are a major concern, though it does not protect against generalized tonic-clonic convulsions [3][11].
  • Clobazam: Often used as an “add-on” to improve control when other medications aren’t enough, but parents must monitor for side effects like sedation, and over time the body can build a tolerance to it [1][12].

Options for Drug-Resistant EEM

In more than 50% of cases, EEM can be “drug-resistant,” meaning seizures continue even after trying two or more appropriately chosen medications [2][13]. When this happens, non-medication options may be considered:

  1. Modified Atkins Diet (MAD): This is a high-fat, low-carbohydrate diet that is less restrictive than a traditional ketogenic diet but still requires medical supervision [14]. In a small study of children with EEM, all participants saw a reduction in seizures by more than 50% after six months on the diet [14]. However, this diet carries practical risks, including nutritional deficiencies, kidney stones, and gastrointestinal issues, and results are not guaranteed.
  2. Vagus Nerve Stimulation (VNS): This involves a small device implanted under the skin that sends regular electrical pulses to the brain via the vagus nerve [15]. While not a “cure,” about one-third of children with drug-resistant EEM in a small study saw a 50% or greater improvement in their seizure frequency [15]. VNS is an “add-on” therapy rather than a cure, and it carries surgical and device-related risks.

If your child’s seizures remain difficult to control, a referral to a comprehensive epilepsy center is often the next step. These centers have specialized teams who can perform advanced video-EEG monitoring, genetic evaluations, and coordinate complex treatments like dietary therapy [16][17].

Common questions in this guide

What medicine is usually considered first for epilepsy with eyelid myoclonia?
Valproate, also called valproic acid, is widely considered the most effective starting medicine because it can treat eyelid fluttering, absence seizures, and generalized convulsions. A neurologist must weigh its benefits against side effects and reproductive risks before prescribing it.
Why are some common seizure medicines avoided in EEM?
Carbamazepine, oxcarbazepine, and phenytoin can aggravate generalized seizures in EEM, so they are generally avoided. Isolated reports also describe worsening eyelid fluttering with cannabidiol, so any use should be discussed closely with the treating neurologist.
What are alternatives to valproate for a child who may become pregnant in the future?
Levetiracetam and lamotrigine are commonly considered alternatives when future pregnancy is a concern. Levetiracetam can cause irritability or behavior changes, while lamotrigine must be increased slowly because of rash risk and may worsen some myoclonic jerks.
What can be added if the first medicine does not fully control seizures?
Doctors may add or switch to another medicine, depending on which seizure types remain. Ethosuximide is mainly helpful for absence seizures and does not protect against generalized tonic-clonic convulsions, while clobazam may be used as an add-on but can cause sedation and lose effect over time.
What treatments are available for drug-resistant EEM?
Drug-resistant EEM means seizures continue after two appropriately chosen medicines have been tried. Under medical supervision, options may include the Modified Atkins diet or vagus nerve stimulation; these can reduce seizures for some children but are not guaranteed cures and carry their own risks.
When should a child with EEM be evaluated at a comprehensive epilepsy center?
A referral is often considered when seizures remain uncontrolled after the first two appropriate medicines or when treatment choices are complex. A specialized center can coordinate video-EEG monitoring, genetic evaluation, dietary therapy, and other treatment planning.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Epilepsy with eyelid myoclonia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Considering the risk of worsening seizures, which specific sodium-channel blockers should we ensure are removed from my child's potential treatment options?
  2. 2.Since valproate is often considered the most effective for this syndrome, how do we balance that benefit against the long-term reproductive risks if my child is female?
  3. 3.If we choose levetiracetam or lamotrigine as first-line alternatives, what is the plan if they do not provide sufficient seizure control?
  4. 4.How long should we trial a specific medication before deciding it is not working and considering a transition to a second-line option like ethosuximide or clobazam?
  5. 5.Is our child a candidate for a specialized epilepsy center evaluation if their seizures are not controlled by the first two medications we try?

References

References (17)
  1. 1

    Management of epilepsy with eyelid myoclonia: Results of an international expert consensus panel.

    Smith KM, Wirrell EC, Andrade DM, et al.

    Epilepsia 2023; (64(9)):2342-2350 doi:10.1111/epi.17682.

    PMID: 37326215
  2. 2

    A comprehensive narrative review of epilepsy with eyelid myoclonia.

    Smith KM, Wirrell EC, Andrade DM, et al.

    Epilepsy research 2023; (193()):107147 doi:10.1016/j.eplepsyres.2023.107147.

    PMID: 37121024
  3. 3

    Jeavons Syndrome: Clinical Features and Response to Treatment.

    Smith KM, Youssef PE, Wirrell EC, et al.

    Pediatric neurology 2018; (86()):46-51 doi:10.1016/j.pediatrneurol.2018.06.001.

    PMID: 30082241
  4. 4

    Potential of cenobamate as a broad-spectrum antiseizure medication.

    Melnick SM, Misra SN, Kamin M, et al.

    Expert opinion on pharmacotherapy 2025; (26(10)):1177-1189 doi:10.1080/14656566.2025.2517352.

    PMID: 40472145
  5. 5

    Valproic Acid in Women of Reproductive Potential: Panacea or Pandora's Box.

    Koshy KG, Iype M

    Neurology India 2025; (73(5)):967-972 doi:10.4103/neurol-india.Neurol-India-D-24-00937.

    PMID: 40946275
  6. 6

    Epilepsy with Eyelid Myoclonia Complicated by Polycystic Ovary Syndrome: Valproate Withdrawal, Vagus Nerve Stimulation, and Seizure Reduction.

    Tatebayashi K, Takumi I, Matsumori T, et al.

    NMC case report journal 2023; (10()):321-325 doi:10.2176/jns-nmc.2023-0083.

    PMID: 38076393
  7. 7

    Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy.

    Tomson T, Battino D, Bromley R, et al.

    Epileptic disorders : international epilepsy journal with videotape 2019; (21(6)):497-517 doi:10.1684/epd.2019.1105.

    PMID: 31782407
  8. 8

    Unmasking of myoclonus by lacosamide in generalized epilepsy.

    Birnbaum D, Koubeissi M

    Epilepsy & behavior case reports 2017; (7()):28-30 doi:10.1016/j.ebcr.2016.09.006.

    PMID: 28239547
  9. 9

    The spectrum of epilepsy in children with 15q13.3 microdeletion syndrome.

    Whitney R, Nair A, McCready E, et al.

    Seizure 2021; (92()):221-229 doi:10.1016/j.seizure.2021.09.016.

    PMID: 34601452
  10. 10

    Exacerbation of eyelid myoclonia in patients with epilepsy and eyelid myoclonia receiving cannabidiol.

    Zawar I, Franic L, Kotagal P, Knight EP

    Epileptic disorders : international epilepsy journal with videotape 2021; (23(6)):906-910 doi:10.1684/epd.2021.1338.

    PMID: 34642157
  11. 11

    Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes.

    Mastroianni G, Ascoli M, Gasparini S, et al.

    Expert review of clinical pharmacology 2021; (14(11)):1427-1433 doi:10.1080/17512433.2021.1959317.

    PMID: 34289757
  12. 12

    Epilepsy associated with SYNGAP1 gene variants: clinical features of six cases and a literature review.

    Zhang W, Wang Y, Xu K, et al.

    Frontiers in pediatrics 2026; (14()):1789561 doi:10.3389/fped.2026.1789561.

    PMID: 42130800
  13. 13

    Prognostic factors in patients with refractory idiopathic generalized epilepsy.

    Gomez-Ibañez A, McLachlan RS, Mirsattari SM, et al.

    Epilepsy research 2017; (130()):69-73 doi:10.1016/j.eplepsyres.2017.01.011.

    PMID: 28157601
  14. 14

    Modified Atkins diet in children with epilepsy with eyelid myoclonia (Jeavons syndrome).

    Paibool W, Schimpf S, Nordli DR, Phitsanuwong C

    Epilepsy & behavior : E&B 2023; (145()):109347 doi:10.1016/j.yebeh.2023.109347.

    PMID: 37459720
  15. 15

    The role of Vagus nerve stimulation in epilepsy with eyelid myoclonia - A case series.

    Snehal I, Lundstrom BN, Wong-Kisiel LC, et al.

    Epilepsy & behavior : E&B 2026; (184()):111201 doi:10.1016/j.yebeh.2026.111201.

    PMID: 42462393
  16. 16

    Clinical presentation and evaluation of epilepsy with eyelid myoclonia: Results of an international expert consensus panel.

    Smith KM, Wirrell EC, Andrade DM, et al.

    Epilepsia 2023; (64(9)):2330-2341 doi:10.1111/epi.17683.

    PMID: 37329145
  17. 17

    Are the seizures under control or unnoticed? Electroclinical evaluation of epilepsy with eyelid myoclonia.

    Atacan Yasguclukal M, Gulec B, Deniz Elmali A, et al.

    Epilepsy & behavior : E&B 2024; (157()):109895 doi:10.1016/j.yebeh.2024.109895.

    PMID: 38905913

This page is for informational purposes only and does not constitute medical advice. Never start, stop, or change a child's antiseizure medicine or diet for epilepsy with eyelid myoclonia without direct guidance from the prescribing neurologist.